NEW YORK and WALTHAM, Mass.--(BUSINESS WIRE)--The Multiple Sclerosis Research Center of New York (MSRCNY) and BG Medicine today announced that the two organizations have entered into an agreement to collaborate on research in the area of multiple sclerosis. Initial projects under the agreement are expected to be the discovery of biomarkers of MS disease activity and biomarkers of efficacy and safety for a currently marketed MS drug treatment.
